• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

刺孢霉素γ1I:一种能特异性切割双链DNA的抗肿瘤抗生素。

Calicheamicin gamma 1I: an antitumor antibiotic that cleaves double-stranded DNA site specifically.

作者信息

Zein N, Sinha A M, McGahren W J, Ellestad G A

机构信息

Infectious Disease Research Section, American Cyanamid Company, Lederle Laboratories, Pearl River, NY 10965.

出版信息

Science. 1988 May 27;240(4856):1198-201. doi: 10.1126/science.3240341.

DOI:10.1126/science.3240341
PMID:3240341
Abstract

Calicheamicin gamma 1I is a recently discovered diyne-ene--containing antitumor antibiotic with considerable potency against murine tumors. In vitro, this drug interacts with double-helical DNA in the minor groove and causes site-specific double-stranded cleavage. It is proposed that the observed cleavage specificity is a result of a unique fit of the drug and DNA followed by the generation of a nondiffusible 1,4-dehydrobenzene--diradical species that initiates oxidative strand scission by hydrogen abstraction on the deoxyribose ring. The ability of calicheamicin gamma 1I to cause double-strand cuts at very low concentrations may account for its potent antitumor activity.

摘要

加利车霉素γ1I是一种最近发现的含二炔-烯的抗肿瘤抗生素,对鼠类肿瘤有相当强的效力。在体外,这种药物在小沟中与双螺旋DNA相互作用,并导致位点特异性双链切割。有人提出,观察到的切割特异性是药物与DNA独特契合的结果,随后产生一种不可扩散的1,4-脱氢苯双自由基物种,该物种通过从脱氧核糖环上夺取氢引发氧化链断裂。加利车霉素γ1I在极低浓度下引起双链切割的能力可能解释了它强大的抗肿瘤活性。

相似文献

1
Calicheamicin gamma 1I: an antitumor antibiotic that cleaves double-stranded DNA site specifically.刺孢霉素γ1I:一种能特异性切割双链DNA的抗肿瘤抗生素。
Science. 1988 May 27;240(4856):1198-201. doi: 10.1126/science.3240341.
2
Solution structure of the calicheamicin gamma 1I-DNA complex.刺孢霉素γ1I-DNA复合物的溶液结构
J Mol Biol. 1997 Jan 17;265(2):187-201. doi: 10.1006/jmbi.1996.0718.
3
Calicheamicin gamma 1I and DNA: molecular recognition process responsible for site-specificity.
Science. 1989 May 12;244(4905):697-9. doi: 10.1126/science.2717946.
4
Some characteristics of DNA strand scission by macromolecular antitumor antibiotic C-1027 containing a novel enediyne chromophore.含新型烯二炔发色团的大分子抗肿瘤抗生素C-1027引起的DNA链断裂的一些特性
Biochemistry. 1993 Jun 1;32(21):5548-53. doi: 10.1021/bi00072a008.
5
C1027 chromophore, a potent new enediyne antitumor antibiotic, induces sequence-specific double-strand DNA cleavage.C1027生色团,一种强效的新型烯二炔类抗肿瘤抗生素,可诱导序列特异性双链DNA切割。
Biochemistry. 1994 May 17;33(19):5947-54. doi: 10.1021/bi00185a036.
6
Cleavage behavior of calicheamicin gamma 1 and calicheamicin T.
Proc Natl Acad Sci U S A. 1992 May 15;89(10):4608-12. doi: 10.1073/pnas.89.10.4608.
7
Hydroxyl radical footprinting of calicheamicin. Relationship of DNA binding to cleavage.
Biochemistry. 1994 Jan 18;33(2):614-21. doi: 10.1021/bi00168a029.
8
Cleavage by calicheamicin gamma 1I of DNA in a nucleosome formed on the 5S RNA gene of Xenopus borealis.加利车霉素γ1I对在北极爪蟾5S RNA基因上形成的核小体中的DNA的切割作用。
Biochemistry. 1995 Mar 28;34(12):3899-906. doi: 10.1021/bi00012a005.
9
The carbohydrate domain of calicheamicin gamma I1 determines its sequence specificity for DNA cleavage.刺孢霉素γ I1的碳水化合物结构域决定了其对DNA切割的序列特异性。
Proc Natl Acad Sci U S A. 1991 Sep 1;88(17):7464-8. doi: 10.1073/pnas.88.17.7464.
10
Synthetic calicheamicin mimics with novel initiation mechanisms: DNA cleavage, cytotoxicity, and apoptosis.具有新型起始机制的合成加利车霉素类似物:DNA裂解、细胞毒性和细胞凋亡。
Chem Biol. 1994 Sep;1(1):57-66. doi: 10.1016/1074-5521(94)90041-8.

引用本文的文献

1
Sequential Reconstruction of Calicheamicin γ Iodo-Thiobenzoate by Selective Carrier Protein Trapping Reveals a Flavin-Dependent Iodinase.通过选择性载体蛋白捕获对刺孢霉素γ-碘硫苯甲酸酯进行顺序重建揭示了一种黄素依赖性碘化酶。
Angew Chem Int Ed Engl. 2025 Aug 18;64(34):e202506825. doi: 10.1002/anie.202506825. Epub 2025 Jun 29.
2
Advancing Breast Cancer Treatment: The Role of Immunotherapy and Cancer Vaccines in Overcoming Therapeutic Challenges.推进乳腺癌治疗:免疫疗法和癌症疫苗在克服治疗挑战中的作用。
Vaccines (Basel). 2025 Mar 24;13(4):344. doi: 10.3390/vaccines13040344.
3
Antibody-Based and Other Novel Agents in Adult B-Cell Acute Lymphoblastic Leukemia.
成人B细胞急性淋巴细胞白血病中基于抗体的及其他新型药物
Cancers (Basel). 2025 Feb 25;17(5):779. doi: 10.3390/cancers17050779.
4
Therapeutic Strategies for Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia in Adult Patients: Optimizing the Use of Monoclonal Antibodies.成人复发或难治性B细胞急性淋巴细胞白血病的治疗策略:优化单克隆抗体的使用
Eur J Haematol. 2025 Jun;114(6):938-952. doi: 10.1111/ejh.14405. Epub 2025 Mar 6.
5
Six events that shaped antibody approvals in oncology.塑造肿瘤学领域抗体药物获批情况的六大事件。
Front Immunol. 2025 Feb 10;16:1533796. doi: 10.3389/fimmu.2025.1533796. eCollection 2025.
6
DNTT-mediated DNA damage response drives inotuzumab ozogamicin resistance in B-cell acute lymphoblastic leukemia.DNTT介导的DNA损伤反应驱动B细胞急性淋巴细胞白血病中奥英妥珠单抗耐药。
Blood. 2025 Mar 13;145(11):1182-1194. doi: 10.1182/blood.2024026085.
7
Ph- ALL: immunotherapy in upfront treatment.Ph 阳性急性淋巴细胞白血病:一线治疗中的免疫疗法
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):86-92. doi: 10.1182/hematology.2024000531.
8
Present Scenario and Future Landscape of Payloads for ADCs: Focus on DNA-Interacting Agents.抗体偶联药物(ADCs)的载荷当前情况与未来前景:聚焦于DNA相互作用剂
Pharmaceuticals (Basel). 2024 Oct 7;17(10):1338. doi: 10.3390/ph17101338.
9
Therapeutic antibodies in oncology: an immunopharmacological overview.肿瘤学中的治疗性抗体:免疫药理学概述。
Cancer Immunol Immunother. 2024 Oct 3;73(12):242. doi: 10.1007/s00262-024-03814-2.
10
Tunable and Photoactivatable Mimics of Calicheamicin γ for DNA Cleavage.可调节和光激活的 calicheamicin γ 类似物用于 DNA 切割。
J Am Chem Soc. 2024 Sep 18;146(37):25416-25421. doi: 10.1021/jacs.4c07754. Epub 2024 Sep 9.